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OBJECTIVES The goal of this study was to develop and validate a method to estimate left ventricular
end-systolic elastance (Ees) in humans from noninvasive single-beat parameters.
BACKGROUND Left ventricular end-systolic elastance is a major determinant of cardiac systolic function and
ventricular-arterial interaction. However, its use in heart failure assessment and management
is limited by lack of a simple means to measure it noninvasively. This study presents a new
noninvasive method and validates it against invasively measured Ees.
METHODS Left ventricular end-systolic elastance was calculated by a modified single-beat method
employing systolic (Ps) and diastolic (Pd) arm-cuff pressures, echo-Doppler stroke volume
(SV), echo-derived ejection fraction and an estimated normalized ventricular elastance at
arterial end-diastole (ENd): Ees(sb)  [Pd  (ENd(est)  Ps  0.9)]/(ENd(est)  SV). The ENd
was estimated from a group-averaged value adjusted for individual contractile/loading effects;
Ees(sb) estimates were compared with invasively measured values in 43 patients with varying
cardiovascular disorders, with additional data recorded after inotropic stimulation (n  18,
dobutamine 5 to 10 g/kg per min). Investigators performing noninvasive analysis were
blinded to the invasive results.
RESULTS Combined baseline and dobutamine-stimulated Ees ranged 0.4 to 8.4 mm Hg/ml and was
well predicted by Ees(sb) over the full range: Ees  0.86  Ees(sb)  0.40 (r  0.91, SEE 
0.64, p  0.00001, n  72). Absolute change in Ees(sb) before and after dobutamine also
correlated well with invasive measures: Ees(sb): Ees  0.86  Ees(sb)  0.67 (r  0.88, p 
0.00001). Repeated measures of Ees(sb) over two months in a separate group of patients (n 
7) yielded a coefficient of variation of 20.3  6%.
CONCLUSIONS The Ees can be reliably estimated from simple noninvasive measurements. This approach
should broaden the clinical applicability of this useful parameter for assessing systolic
function, therapeutic response and ventricular-arterial interaction. (J Am Coll Cardiol
2001;38:2028–34) © 2001 by the American College of Cardiology
The effectiveness of chronic heart failure therapy depends
upon an accurate assessment of the underlying pathophys-
iology, accompanied by close patient monitoring and tai-
lored treatment (1–3). Such comprehensive management
approaches stabilize acute exacerbations, reduce readmis-
sions, enhance quality of life and improve survival (1–3).
However, variability of disease presentation and its response
to treatment (3–5) and a growing complexity of therapeutic
options have increased the need for more specific and better
measures of cardiac performance.
Routine approaches for assessing left ventricular (LV)
function are based largely on image-analysis or right-heart
monitoring. Both are useful yet provide limited information
specific to the LV, and neither indexes ventricular-arterial
interactions, which can be crucial for optimizing chronic
therapy (6–9). The end-systolic pressure-volume relation
(ESPVR) and its slope (Ees) have proven very useful in this
regard since Ees is a major determinant of LV systolic
performance and heart interaction with the systemic vascu-
lature (8–13). However, Ees determination has generally
required invasively measured LV pressure and volumes
recorded over a range of cardiac loading. This has hampered
the broader application of this parameter to clinical heart
failure diagnosis and management.
Several approaches have been proposed for estimating Ees
without loading interventions (14–16), and these are gen-
erally referred to as single-beat methods (Ees(sb)). For
example, based on similarities between the amplitude and
time-normalized human LV time-varying elastance curves
during early isovolumic contraction, we reported that Ees
could be estimated from steady-state data (15). This ap-
proach has been since applied to other species as well (17).
Subsequent studies (16) improved on this approach by
individually adjusting the normalized elastance curve to
compensate for load and contractility dependencies.
A strength of these particular methods (14,16) is their
potential to be used noninvasively. While this has already
been attempted (18), there are no data validating the
noninvasive approach by comparing it with directly mea-
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sured (multiple-cycle derived) invasive Ees. In this study, we
developed a modified noninvasive method for Ees(sb) and
verified this method by comparisons with results obtained
from invasive (multiple-beat) analysis.
METHODS
Study population. The primary study group consisted of
43 patients studied in the cardiac catheterization laborato-
ries of the Johns Hopkins Hospital (n  11) or Taipei
Veterans General Hospital, Taiwan (n  32). Invasive and
noninvasive pressure-volume data were measured simulta-
neously at the first center and within 1 to 2 h of each other
at the latter center. For simultaneous studies, a custom
light-weight radio-lucent horizontal tilt-table was attached
to the catheterization table to position patients for echo-
Doppler recording. Thirty-four men and nine women were
studied, with a mean age of 62  12 years. Primary
indications for cardiac catheterization were chest pain (n 
26) or heart failure (n  17). Clinical diagnoses included
noncardiac disease (normal coronary artery anatomy and LV
systolic function, n  13), coronary artery disease (n  13),
hypertensive cardiac disease (n  8), dilated cardiomyopa-
thy (n  5), hypertrophic cardiomyopathy (n  1), con-
strictive pericarditis (n  1) and heart transplantation (n 
2). Ejection fraction (EF) ranged from 17% to 88% (mean:
69  15%).
Additional studies were obtained by noninvasive method
in seven subjects with vascular stiffening and normal heart
function (placebo arm of pharmacologic study) to test
measurement reproducibility over time. All patients pro-
vided informed consent, and the relevant institutional re-
view board for each respective institution approved the
protocol(s).
Study protocol. Patients underwent routine coronary an-
giography, left ventriculography and right heart catheteriza-
tion. A 7F multielectrode conductance/micromanometer
catheter was then placed into the LV, with the pigtail tip
advanced to the ventricular apex. Left ventricular volumes
were recorded using a stimulator-microprocessor (Sigma V,
CardioDynamics, the Netherlands) and calibrated to match
thermodilution-derived stroke volume (SV) and contrast
ventriculogram-derived EF. Echocardiograms were per-
formed (Sonos-5500, Agilent, Palo Alto, California) using
a wide-band frequency-fusion phase-array transducer. Bra-
chial systolic (Ps) and diastolic (Pd) blood pressures were
obtained with an oscillometric blood pressure monitor.
End-systolic pressure (Pes) was estimated from Ps  0.9
(19). This was further tested in 17 subjects in whom
concomitant brachial cuff pressure and invasive data were
measured, yielding a linear relation with slope 1.01, p 
0.0001, r  0.75. Left ventricular outflow tract diameter
was measured at the base of the aortic leaflets in a paraster-
nal long-axis view from which cross-sectional area was
determined. Stroke volume was measured from proximal
aorta pulse-wave Doppler-flow (apical five-chamber view)
and aortic cross-sectional area (20). A standard method was
used to calculate LV EF from two-dimensional guided
M-mode echocardiographic data (21).
In addition to rest data, noninvasive and invasive assess-
ments were made in 18 patients before and after varying
contractility by dobutamine (5 to 10 g/kg per min,
intravenous). Comparisons were simultaneous in five studies
and sequential (separated by 1 to 2 h) in the others. A total
of 29 pre/post dobutamine comparisons were obtained (two
doses in most patients).
Ees(sb) estimation algorithm. The algorithm for Ees(sb)
assumed a linear end-systolic pressure-volume relation in
the measured data range and a constant volume axis inter-
cept of the end-systolic pressure volume relation (V0). Using
pressures and volumes determined at times during midiso-
volumic contraction (td) and at end-systole (tes), two values
of LV elastance were derived: Ed  Pd/(Vd  V0) and Ees 
Pes /(Ves  V0). Their ratio ENd (Ed/Ees) was the time and
amplitude normalized time varying elastance at time td. We
found that values of ENd were conserved during the isovolu-
mic period in humans despite diverse cardiac disease, heart
function and arterial load. Thus, knowledge of td meant that
ENd and, thereby, Ees and V0 could be derived (14).
The prior study of Senzaki et al. (14) sampled pressures
and volumes at several time points during isovolumic contrac-
tion (i.e., multiple values of td). This was easily achieved since
both signals were measured invasively, and the final Ees
estimate averaged separate calculations. For noninvasive anal-
ysis, however, a single pressure-volume point is used, timed at
the onset of ejection (end of the isovolumic period). By
substituting arterial diastolic pressure for end-isovolumic LV
pressure and arterial systolic pressure for LV end-systolic
pressure, one obtains (see Appendix for details):
Eessb	  
Pd  ENd  Ps  0.9	/
Ved  Ves	  ENd
 
Pd  ENd  Ps  0.9	/
SV ENd [1]
Abbreviations and Acronyms
Ed  left ventricular end-diastolic elastance
Ees  left ventricular end-systolic elastance
Ees(sb)  left ventricular elastance at end-systole derived
by single-beat technique
EF  ejection fraction
ENd(avg)  group-averaged normalized left ventricular
elastance at the onset of ejection
ENd(est)  noninvasive estimated normalized left
ventricular elastance at the onset of ejection
ESPVR  end-systolic pressure volume relation
LV  left ventricle or left ventricular
Pd  diastolic arterial pressure
Pes  left ventricular end-systolic pressure
Ps  systolic arterial pressure
SV  stroke volume
Vd  left ventricular volume at the onset of ejection
Ved  left ventricular end-diastolic volume
Ves  left ventricular end-systolic volume
V0  volume axis intercept of the end-systolic
pressure volume relation
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where Ved and Ves are end-diastolic and end-systolic vol-
umes, SV is stroke volume, ENd is the normalized elastance
value at the onset of ejection and Pd and Ps are arterial
diastolic and systolic pressures, respectively.
The accuracy of equation 1 is dependent on the reliability
of the measured data and the value chosen for ENd. Our
prior study employed high-fidelity pressure/volume signals
to yield accurate timing for ENd determination and early
isovolumic contraction data to minimize intrapatient vari-
ability about the group-averaged normalized LV elastance at
the onset of ejection (ENd(avg)) value. For noninvasive
application, ENd occurs at the onset of ejection, increasing
individual load/contractile-dependent deviations from the
population average. To reduce this variance, we developed
an approach similar to that of Shishido et al. (16) using a
regression model to improve the individual noninvasive
estimated normalized LV elastance at the onset of ejection
(ENd(est)) for each patient, based on noninvasive measures of
systolic function (EF) and arterial load (ratio of arterial
diastolic to systolic pressure).
The ENd(est) regression-model was based on data ob-
tained in 23 completely separate and previously recorded
studies in which invasive aortic pressure and LV pressure-
volume data were concomitantly measured. An individual
time-varying elastance function was calculated from rest
steady-state data, with V0 in this calculation based on
multicycle ESPVR analysis as previously described (14).
This curve was normalized by amplitude and time, and its
value at the upstroke of aortic pressure determined. This
served as the “gold standard” value for ENd. The ENd(est) was
obtained from a group-averaged normalized elastance curve
value at this same time td (ENd(avg)), baseline EF and the
ratio of arterial diastolic to systolic pressure (Pd/Pes), given
by:
ENdest	  0.0275  0.165  EF  0.3656  Pd/Pes	
 0.515  ENdavg	 [2]






where ai are (0.35695, 7.2266, 74.249, 307.39, 684.54,
856.92, 571.95, 159.1) for i  0 to 7, respectively. The
value of tNd was determined by the ratio of pre-ejection
period (R wave 3 flow-onset) to total systolic period
(R-wave3 end-flow), with the time at onset and termina-
tion of flow defined noninvasively from the aortic Doppler
waveform. Each factor in equation 2 was a significant
independent contributor to the regression. Figure 1 com-
pares ENd(est) with directly measured ENd. The regression
yielded an overall r  0.88 and p  0.00001, with a SEE
about 10% the mean. The Ees(sb) was then derived by
combining equations 1 and 2:
Eessb	  
Pd  ENdest	  Ps  0.9	/
SV  ENdest	
[3]
Statistical methods. Results are expressed as mean  SD.
Univariate linear regression was performed to test the
agreement between noninvasively estimated and invasively
measured Ees values at rest and changes in Ees induced by
dobutamine. Bland-Altman analysis was employed to assess
for systematic bias in the correlation.
RESULTS
Estimation of Ees by Ees(sb) Figure 2A displays typical
pressure-volume loop data used to derive invasive Ees. The
ESPVRs were generally linear over the observed data range.
Figure 2B shows the corresponding noninvasive analysis
displayed as two pressure-volume points (solid and open
circles). From these points, equations 1 and 2 were used to
determine Ees(sb). Figure 2C and 2D show similar examples
before and after dobutamine infusion. The plots demon-
strate a generally good correlation between directly mea-
sured Ees and the noninvasive estimate.
Figure 3A displays group regression results for 43 base-
line comparisons between invasive Ees and the single-beat
noninvasive Ees(sb) estimate. The regression equation was:
Ees  0.78  Ees(sb)  0.55 (r  0.81, SEE  0.50, p 
0.0001). The mean difference was 0.03 mm Hg/ml (95%
confidence interval: 0.14 3 0.19), that is, no systematic
bias, and 80% of the estimate errors fell below 0.6 mm Hg.
Figure 3C shows combined baseline and postdobutamine
data, extending the range of Ees comparisons nearly twofold
and improving the strength of the overall correlation. The
regression SEE was 0.64, with the mean error of 0.43  0.5
(again with no bias) and with about 75% of the estimates
falling within 0.6 mm Hg/ml of the measured value.
Figure 1. Estimation of normalized time-varying elastance value at the
onset of ejection for individual subjects. The estimate is based on the
group-averaged value (14), resting ejection fraction and the ratio of
diastolic to systolic arterial pressure (equation 2). Plot shows correlation
between predicted normalized left ventricular elastance at the onset of
ejection (ENd) and directly measured value.
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Relative changes in Ees by dobutamine. To further test
the robustness of the noninvasive method, the estimated
change in Ees induced by dobutamine in each patient was
compared with the directly measured change based on
invasive loop analysis (Fig. 3C and 3D) . The results (Fig.
4) revealed a good correlation given by: Ees  0.86 
Ees(sb)  0.29 (r  0.88, SEE  0.67, p  0.0001).
Comparison with Pes/Ves ratio. The steady-state ratio of
end-systolic pressure to end-systolic volume (Pes/Ves) is the
most commonly employed approximation for Ees, particu-
larly for noninvasive use. It makes a simple assumption that
the volume axis intercept of the ESPVR is zero. To
determine if the Ees(sb) provided additional accuracy over
this more easily measured ratio, we compared Pes/Ves to
invasive Ees. The results shown in Figure 5 demonstrate that
Pes/Ves was less well-correlated with Ees (r  0.56) com-
pared with Ees(sb) and consistently overestimated Ees, par-
ticularly at higher values. The residuals (Fig. 5B) were
significantly different from zero, averaging 2.2 mm Hg/ml.
This result contrasts with that for Ees(sb), which yielded a
relation closer to the identity line.
Reproducibility of Ees(sb). To test the chronic reproduc-
ibility of Ees(sb) measurements, the noninvasive parameter
was measured over three successive months in seven subjects
with systolic hypertension enrolled in a randomized
placebo-controlled trial of a novel antihypertension agent.
These patients were those subsequently found to be on
placebo. Data were obtained at baseline and monthly for
two months, each measured in a fasting state in the
morning. Mean Ees(sb) was 3.3  0.94, 3.6  1.3 and 3.1 
1.1 at the three observation points, with an average coeffi-
cient of variation of 20  6%. Variability of Ees(sb) was
primarily related to that of SV (cov [coefficient of variation] 
14  6.6%).
DISCUSSION
We developed and tested a novel fully noninvasive method
for estimating Ees. The method requires five easily measured
parameters obtained from noninvasive arm-cuff blood pres-
sures, echo-Doppler cardiography and the electrocardio-
gram. This is the only study to date to directly verify a fully
noninvasive estimation method against invasive multiple
cycle-derived pressure-volume relations in humans.
The correlations between measured and estimated Ees(sb)
values at rest and with acute contractility change were
generally good, and there was reasonable repeated-
measurement reproducibility over time. It is important in
this regard to consider the accuracy of the new estimation
method relative to likely clinical applications. The majority
(between 75% to 80%) of absolute discrepancies between
Ees(sb) and the invasive “goal-standard” value were smaller
Figure 2. (A) Invasive pressure-volume loops and analysis used to derive (Ees). Multiple beats are recorded before and during transient obstruction of the
inferior vena cava. (B) Noninvasive assessment of (Ees(sb)) displayed in pressure-volume plane from the same example. Two sets of (volume, pressure) data
points are measured and used to predict Ees(sb). The dotted area represents a schematic pressure-volume loop based on these points. From these data, Ees(sb)
is estimated using equation 4. (C) Example of pressure-volume data at rest and after dobutamine stimulation. (D) Corresponding noninvasive Ees(sb) for
the same example displayed in C. Light and darkened dotted areas are schematic loops from the two points. Pd  diastolic arterial pressure at the onset
of ejection; Pes  left ventricular end-systolic pressure; SV  stroke volume; Ved  left ventricular end-diastolic pressure; Ves  left ventricular
end-systolic volume.
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than 0.6 mm Hg/ml (consistent with SEE from regression
analysis). The Ees typically ranges near 2.0 mm Hg/ml in
normal hearts (13), 1.0 mm Hg/ml in dilated failing
hearts (12) and about 4.0 mm Hg/ml in hypertrophied
hearts (22). Thus, an absolute error of 0.6 mm Hg/ml
should be adequate to correctly identify most patients
within these populations. The 20% variability observed with
repeated measures suggests that Ees(sb) estimates are unlikely
to cross between disease groups by pure chance. However, it
also indicates that moderate changes are likely needed for
the new method to detect real alterations in Ees(sb) over time
or with interventions.
Comparison with other single-beat analysis meth-
ods. Several prior studies have reported methods for esti-
mating Ees from single-beat data. Most commonly, the
Pes/Ves ratio is calculated. However, the assumption that the
ESPVR passes through the origin in humans results in
consistent overestimation of true Ees and substantially
greater prediction variance (Fig. 5) (14). Kameyama et al.
(9) used a more complex noninvasive analysis to estimate Ees
based on pressure-cuff calibrated subclavian artery pulse
tracings, echocardiography imaging and load interventions.
This approach, and recent adaptations employing acoustic
quantification methodology (23), remain limited by a need
for varying load, which can result in unreliable image
quantitation during the loading change. Other efforts to
assess Ees involve curve fitting to the pressure waveform
(15), an approach that seems less reliable than the Ees(sb)
method (14) and is not translatable to noninvasive analysis.
Recently, Shishido et al. (16) proposed a bilinear approx-
imation to the normalized time varying elastance curve
(rising phase only) and found this simple fit provided a
reliable estimate of Ees in anesthetized dogs. Central to their
determination was individual estimation of the point at
which the first linear approximation to rising elastance
transited to the second, an inflection occurring at or near the
onset of ejection. Rather than being independent of loading
or contractile conditions, the inflection point had sensitiv-
ities that could be predicted from EF. Lack of a stable
inflection point might seem to counter our prior clinical
Figure 3. (A) Linear regression (solid line) and 95% confidence intervals (dotted lines) comparing noninvasive left ventricular elastance at end-systole
derived by single-beat technique (Ees(sb)) and invasive (multi-beat) left ventricular end-systolic elastance (Ees) at baseline for 43 subjects. (B) Bland-Altman
plot of Ees(sb)-Ees difference versus mean value. Mean and 99% confidence interval of the mean difference is shown. (C and D) Same analysis as in A and
B but including data after dobutamine stimulation, which expanded the range of Ees comparisons. The correlation between measurements is very good and
falls along the line of identity.
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study (14) in which the elastance waveform was fairly well
conserved during early systole. However, this earlier invasive
analysis relied on data measured during the pre-ejection
isovolumic period, when load and contractile effects on the
elastance curve were minimal. In contrast, the method of
Shishido et al. (16) as well as the present method relied on
data measured solely at the onset of ejection, where these
factors are more influential. Equation 2 in this study was
developed independently yet concurrently with the approach
of Shishido et al. (16) and serves the same purpose as their
regression model to individualize a bilinear elastance. One
noteworthy difference was that the present study developed
the model from an independent patient group and then
applied this to a separate study population.
The new Ees(sb) method should also be contrasted to a
recently described single-beat determination of preload
recruitable stroke work (24). Preload recruitable stroke work
is a useful systolic parameter that typically displays greater
stability to varying loading over Ees and other indexes, and
the recent study by Karunanithi and Feneley (24) extended
this index to single-beat analysis. However, determination
required invasive pressure and volume data, and it is unclear
how easily or well this can be extended to noninvasive
testing. Furthermore, it is more difficult to assess
ventricular-arterial interaction with preload recruitable
stroke work as opposed to Ees, which is an advantage for the
latter in predicting systemic pressure responses to afterload
or preload reduction therapy (11,13).
Study limitations. Technical limitations in the catheter-
ization laboratory precluded simultaneous noninvasive/
invasive analysis in many subjects, and those studies in
which this was achieved still may not have optimized
echo-Doppler imaging. However, this should have intro-
duced greater scatter in our comparison data, not less. This
study also did not evaluate the load-sensitivity of Ees(sb) but,
rather, focused on the correlation between this parameter
and directly measured invasive data. Prior invasive investi-
gations of the Ees(sb) method have demonstrated the lack of
loading influences (14).
As with many prior studies, the current invasive analysis
frequently yielded an apparent negative V0 intercept for the
ESPVR measured in the physiologic data range. This is not
a unique feature of conductance catheter analysis, as similar
findings have been reported in various mammalian species
regardless of the volume method used. As previously dis-
cussed (14), this is mostly related to nonlinear behavior of
the ESPVR at highly reduced load. Importantly, the behav-
ior of the ESVPR in the physiologic loading range defines
the relevant hemodynamic responses; so Ees assessed in this
range is most important. The new noninvasive algorithm
was designed to estimate this operational Ees value, regard-
less of whether it predicted a negative (i.e., nonphysiologic)
V0 based on a purely linear extrapolation.
Figure 4. Paired comparison of change in left ventricular end-systolic
elastance (Ees) induced by dobutamine determined by noninvasive esti-
mation versus the directly assessed value derived from invasive pressure-
volume loops. The noninvasive method provided a good estimate of Ees
(n  29, r  0.88, p  0.0001, with a regression slope and intercept that
were not statistically different from 1.0 and 0, respectively. Ees(sb) 
change in left ventricular end-systolic elastance by single-beat technique.
Figure 5. Comparison of resting end-systolic pressure/volume ratio (Pes/
Ves) as an estimate of elastance to directly measured left ventricular
end-systolic elastance (Ees) by invasive analysis. Unlike Ees(sb) (Fig. 3B), the
pressure-volume ratio consistently overestimated directly measured Ees,
and the regression had a non-zero bias (2.2 mm Hg/ml) as demonstrated
in the lower Bland-Altman plot.
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Conclusions. Left ventricular end-systolic elastance can be
estimated from easily obtained noninvasive parameters, and
the values obtained are generally well correlated with di-
rectly measured data. Besides its implications regarding
contractile strength, Ees values also help clarify integrated
cardiovascular responses to altered vascular loading (8,11–
13,25). In this important sense, it should be useful for
assessing the efficacy of heart failure therapies and targeting
the type of treatment most likely to prove beneficial.
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APPENDIX
The ventricular elastance model for the end-systolic point is:
Ees  Pes/Ves  V0	 [A1]
and for the onset of ventricular ejection point is:
Ed  Pd/Vd  V0	 [A2]
Since by definition, ENd  Ees  Ed, equation A2 can be
rewritten as:
Vd  V0  Pd/ENd	/Ees [A3]
Rearranging equation A1 and combining it with equation
A3 yields:
Vd  Ves  Pd/ENd  Pes	/Ees
 
Pd  ENd Ps	/
ENd  Ees [A4]
which is then solved for Ees:
Ees  
Pd  ENd  Pes	/
Vd  Ves	ENd] [A5]
Left ventricular volume at the onset of ejection (Vd) is
very close to the LV end-diastolic volume, so stroke volume
(SV) can substitute for (Vd  Ves). The Pes is approximated
by the product of brachial systolic pressure Ps  0.9.
Substitution of these variables in equation A5 yields equa-
tion 1 in the Methods section.
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